Regnum Corp. engages in the business of developing and commercializing therapeutics that treat rare and infectious diseases. It focuses on populations that are neglected or face adherence challenges. The company was founded by Tiffani Jones on March 31, 2016 and is headquartered in New York, NY.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company